Insider Transactions in Q4 2022 at Finch Therapeutics Group, Inc. (FNCH)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Oct 21 2022	Marc Blaustein Chief Operating Officer	SELL Open market or private sale	Direct	3,636 -10.03%	$3,636 $1.39 P/Share
Oct 21 2022	Joseph Vittiglio Chief Business & Legal Officer	SELL Open market or private sale	Direct	3,636 -10.39%	$3,636 $1.39 P/Share

Receive a notification when an Institution or Guru buys or sells FNCH shares.

Notify only if

Value

Get notified when an Finch Therapeutics Group, Inc. insider buys or sells FNCH shares.

Notify only if

Operation

Value

Type

Receive news related to Finch Therapeutics Group, Inc.